Opolentisima, Alfredo .

HRN: 28-41-68  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2026
CEFTRIAXONE 1G (VIAL)
01/14/2026
01/21/2026
IV
2g
OD
Diabetic Foot, Left
Waiting Final Action 
01/14/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/14/2026
01/21/2026
IV
600mg
Q8h
Diabetic Foot, Left
Waiting Final Action 
01/15/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
01/15/2026
01/21/2026
TOPICAL
25g
OD
Non Healing Wound
Waiting Final Action 
01/19/2026
LEVOFLOXACIN 500MG (TAB)
01/19/2026
01/26/2026
PO
500mg
OD
Infected Wound
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: